HBLVX
Price
$14.48
Change
-$0.21 (-1.43%)
Updated
Dec 18 closing price
VWIAX
Price
$59.78
Change
-$3.22 (-5.11%)
Updated
Dec 18 closing price
Ad is loading...

HBLVX vs VWIAX

Header iconHBLVX vs VWIAX Comparison
Open Charts HBLVX vs VWIAXBanner chart's image
Hartford Balanced Income R6
Price$14.48
Change-$0.21 (-1.43%)
VolumeN/A
CapitalizationN/A
Vanguard Wellesley® Income Admiral™
Price$59.78
Change-$3.22 (-5.11%)
VolumeN/A
CapitalizationN/A
HBLVX vs VWIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HBLVX vs. VWIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLVX is a Hold and VWIAX is a Hold.

FUNDAMENTALS
Fundamentals
VWIAX has more cash in the bank: 51.3B vs. HBLVX (11.8B). HBLVX (3.62) and VWIAX (3.45) have matching dividends . HBLVX was incepted earlier than VWIAX: HBLVX (10 years) vs VWIAX (24 years). HBLVX is a more actively managed with annual turnover of: 57.00 vs. VWIAX (53.00). HBLVX has a lower initial minimum investment than VWIAX: HBLVX (0) vs VWIAX (50000). HBLVX annual gain was more profitable for investors over the last year : 9.21 vs. VWIAX (7.16). HBLVX return over 5 years is better than : 15.64 vs. VWIAX (4.62).
HBLVXVWIAXHBLVX / VWIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years24 years-
Gain YTD8.0056.202129%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B51.3B23%
Annual Yield % from dividends3.623.45105%
Returns for 1 year9.217.16129%
Returns for 3 years4.86-7.39-66%
Returns for 5 years15.644.62339%
Returns for 10 years42.2722.46188%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VFF0.800.03
+3.86%
Village Farms International
ADIL1.130.03
+3.20%
Adial Pharmaceuticals
RKLB26.370.47
+1.81%
Rocket Lab USA
KYMR42.30-0.76
-1.76%
Kymera Therapeutics
EGBN28.61-0.84
-2.85%
Eagle Bancorp